Synthesis and in vivo biodistribution of BPA–Gd–DTPA complex as a potential MRI contrast carrier for neutron capture therapy
Authors:
- Hiroyuki NakamuraHNHiroyuki Nakamura
- Hiroshi FukudaHFHiroshi Fukuda
- Yoshinori YamamotoYYYoshinori Yamamoto
- 1 February 2005
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 13 (3) , 735-743
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Clinical implementation of 4-dihydroxyborylphenylalanine synthesised by an asymmetric pathwayEuropean Journal of Pharmaceutical Sciences, 2003
- Boron Neutron Capture Therapy of Brain Tumors: An Emerging Therapeutic ModalityNeurosurgery, 1999
- The Radiation Biology of Boron Neutron Capture TherapyRadiation Research, 1999
- The Chemistry of Neutron Capture TherapyChemical Reviews, 1998
- Boron neutron capture therapy: Clinical brain tumor studiesJournal of Neuro-Oncology, 1997
- Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Specific Killing Effect of 10B1-Para-boronophenylalanine in Thermal Neutron Capture Therapy of Malignant Melanoma: In Vitro Radiobiological EvaluationJournal of Investigative Dermatology, 1982
- Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron CompoundsJournal of Medicinal Chemistry, 1967
- Synthesis of Aromatic Boronic Acids. Aldehydo Boronic Acids and a Boronic Acid Analog of Tyrosine1Journal of the American Chemical Society, 1958
- Pathological study of eight patients with glioblastoma multiforme treated by neutroncapture therapy using boron 10Cancer, 1955